The highest dose led to 23.7% average weight loss at 68 weeks when including all participants and 28.7% among those who completed treatment
Missing occasional doses does not significantly impact results
Serious medical concerns Some of the serious concerns with increasing access include: Pancreatitis, Thyroid-related risks, Severe gastric slowing, gall bladder issues, misuse for cosmetic weight loss, self-medication without supervision, muscle loss if not combined with proper nutrition, and weight regain after stopping
doi:10.22074/cellj.2016.4872 [10] Sandhir R, Sood A, Mehrotra A, Kamboj SS
Research shows that certain GLP-1 foods can increase secretion of the hormone by up to 900 percent
In most cases, fatigue improves once eating habits are adjusted